Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LENZ Therapeutics (LENZ) Non Operating Income (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Non Operating Income for 4 consecutive years, with -$417000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 5312.5% to -$417000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 64.32% year-over-year, with the annual reading at -$243000.0 for FY2025, 184.08% down from the prior year.
  • Non Operating Income for Q4 2025 was -$417000.0 at LENZ Therapeutics, down from $2.2 million in the prior quarter.
  • The five-year high for Non Operating Income was $4.1 million in Q2 2024, with the low at -$1.3 million in Q1 2024.
  • Average Non Operating Income over 4 years is $759928.6, with a median of $161000.0 recorded in 2022.
  • The sharpest move saw Non Operating Income surged 2802.97% in 2024, then plummeted 5312.5% in 2025.
  • Over 4 years, Non Operating Income stood at $2.2 million in 2022, then tumbled by 104.69% to -$101000.0 in 2023, then soared by 107.92% to $8000.0 in 2024, then tumbled by 5312.5% to -$417000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$417000.0, $2.2 million, and $199000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.